Stephens Begins Coverage on Nurix Therapeutics (NASDAQ:NRIX)

Stephens initiated coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $20.00 price target on the stock. NRIX has been the subject of several other research reports. Morgan Stanley lifted their price objective on shares of […]

Related Keywords

Canada , China , Entrypoint , British Columbia , Houte Hans Van , Robertw Baird , Nurix Therapeutics Company Profile , Nurix Therapeutics Inc , Royal Bank , Needham Company , International Assets Investment Management , China Universal Asset Management Co , Quest Partners , Wells Fargo Company , Morgan Stanley , Entrypoint Capital , Proshare Advisors , Nurix Therapeutics , Free Report , Moderate Buy , Get Free Report , Hans Van , Universal Asset Management , Point Capital , Share Advisors , Casitasb Lineage , Nurix Therapeutics Daily ,